Target intelligence / Profile preview

Physiological iron-binding proteins and pools

Molecular classification
Transport protein, Storage protein, Metalloprotein, Carrier protein
01

Overview

Physiological iron-binding proteins and pools represent the integrated system of molecules responsible for the transport, storage, and regulation of iron to maintain homeostasis (NIH, 2024). This system includes transport proteins like transferrin, storage proteins such as ferritin and hemosiderin, and the intracellular labile iron pool (LIP), which contains chemically reactive, non-protein-bound iron (PubMed, 2019). These components ensure iron is available for essential processes like oxygen transport and DNA synthesis while preventing the formation of toxic reactive oxygen species through the Fenton reaction (Wikipedia, 2024). In clinical practice, these proteins and pools are the primary targets for iron chelation therapy in conditions of iron overload, such as thalassemia and hemochromatosis, and for iron supplementation in cases of iron deficiency anemia (StatPearls, 2023). Drugs like deferoxamine and deferasirox target the LIP and ferritin stores to remove excess iron, whereas various iron salts and complexes are used to replenish these physiological pools (PubChem, 2024).

Other names
Iron homeostasis systemIron storage and transport proteinsLabile iron pool (LIP)Non-heme iron poolsIron-binding proteins
02

Mechanism of action

Iron chelators bind to the labile iron pool and ferritin-stored iron to form stable, non-toxic complexes that are excreted from the body, while iron supplements provide exogenous iron to replenish depleted ferritin stores and saturate transferrin transport capacity (StatPearls, 2023; PubChem, 2024).

03

Biological functions

Iron homeostasisOxygen transportRedox catalysisDNA synthesisInnate immune response
04

Disease associations

HemochromatosisIron deficiency anemiaThalassemiaNeurodegenerative diseaseCancerInfection
05

Safety considerations

Oxidative stress and tissue damage (Fenton reaction)Liver and cardiac toxicity from iron overloadIncreased risk of infection by siderophilic pathogensGastrointestinal irritation and constipationAgranulocytosis and neutropenia (deferiprone-specific)
06

Interacting drugs

Deferoxamine

7 more in the full profile.

07

Biomarkers

Serum ferritinTransferrin saturation (TSAT)Total iron-binding capacity (TIBC)Soluble transferrin receptor (sTfR)HepcidinHemoglobin

Beyond the preview

Go deeper on Physiological iron-binding proteins and pools.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Physiological iron-binding proteins and pools.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call